Key points are not available for this paper at this time.
Diabetes is a global endemic with rapidly increasing prevalence in both developing and developed countries. The American Diabetes Association has recommended glycated hemoglobin (HbA1c) as a possible substitute to fasting blood glucose for diagnosis of diabetes. HbA1c is an important indicator of long-term glycemic control with the ability to reflect the cumulative glycemic history of the preceding two to three months. HbA1c not only provides a reliable measure of chronic hyperglycemia but also correlates well with the risk of long-term diabetes complications. Elevated HbA1c has also been regarded as an independent risk factor for coronary heart disease and stroke in subjects with or without diabetes. The valuable information provided by a single HbA1c test has rendered it as a reliable biomarker for the diagnosis and prognosis of diabetes. This review highlights the role of HbA1c in diagnosis and prognosis of diabetes patients.
Building similarity graph...
Analyzing shared references across papers
Loading...
Shariq I. Sherwani
The Ohio State University Wexner Medical Center
Haseeb A. Khan
Inje University
Aishah Ekhzaimy
King Saud Medical City
SHILAP Revista de lepidopterología
Biomarker Insights
University of Saskatchewan
King Saud University
King Khalid University Hospital
Building similarity graph...
Analyzing shared references across papers
Loading...
Sherwani et al. (Fri,) studied this question.
synapsesocial.com/papers/69d570b275589c71d767de62 — DOI: https://doi.org/10.4137/bmi.s38440